Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,001 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.
Gkarmiris KI, Lindbäck J, Alexander JH, Granger CB, Kastner P, Lopes RD, Ziegler A, Oldgren J, Siegbahn A, Wallentin L, Hijazi Z. Gkarmiris KI, et al. Among authors: granger cb. J Am Heart Assoc. 2024 Apr 2;13(7):e033720. doi: 10.1161/JAHA.123.033720. Epub 2024 Mar 26. J Am Heart Assoc. 2024. PMID: 38529655 Free article. Clinical Trial.
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.
Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AA, Arntz HR, Bogaerts K, Danays T, Lindahl B, Mäkijärvi M, Verheugt F, Van de Werf F. Wallentin L, et al. Among authors: granger cb. Circulation. 2003 Jul 15;108(2):135-42. doi: 10.1161/01.CIR.0000081659.72985.A8. Epub 2003 Jul 7. Circulation. 2003. PMID: 12847070 Clinical Trial.
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, Harrington RA, Tardiff BE, Granger CB, Ohman EM, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Topol EJ. Roe MT, et al. Among authors: granger cb. Eur Heart J. 2004 Feb;25(4):313-21. doi: 10.1016/j.ehj.2003.12.009. Eur Heart J. 2004. PMID: 14984920 Free article. Clinical Trial.
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, White HD, Wallentin L, Granger CB. Lopes RD, et al. Among authors: granger cb. Heart. 2008 Jul;94(7):867-73. doi: 10.1136/hrt.2007.134486. Epub 2008 Mar 10. Heart. 2008. PMID: 18332062
D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial.
Christersson C, Wallentin L, Andersson U, Alexander JH, Ansell J, De Caterina R, Gersh BJ, Granger CB, Hanna M, Horowitz JD, Huber K, Husted S, Hylek EM, Lopes RD, Siegbahn A. Christersson C, et al. Among authors: granger cb. J Thromb Haemost. 2014 Sep;12(9):1401-12. doi: 10.1111/jth.12638. Epub 2014 Jul 24. J Thromb Haemost. 2014. PMID: 24942912 Free article. Clinical Trial.
Safety and efficacy outcomes of left atrial posterior wall isolation compared to pulmonary vein isolation and pulmonary vein isolation with linear ablation for the treatment of persistent atrial fibrillation.
Sutter JS, Lokhnygina Y, Daubert JP, Bahnson T, Jackson K, Koontz JI, Sun AY, Hegland DD, Thomas KL, Jackson L, Lewis R, Granger C, Piccini JP, Atwater BD. Sutter JS, et al. Am Heart J. 2020 Feb;220:89-96. doi: 10.1016/j.ahj.2019.11.010. Epub 2019 Nov 22. Am Heart J. 2020. PMID: 31805423
1,001 results